Clinical Trials

Find a Trial

Trial Summary

Protocol No.A151216
StatusOPEN TO ACCRUAL
Principal InvestigatorJalal, Shadia
ScopeNational
PhaseNA
Age GroupAdult
TitleAdjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
DescriptionThis research trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Key EligibilityIn order to be eligible to take part in this trial, patients must meet the following criteria:
  • Clinical stage IB (>= 4 cm), II or IIIA non-squamous non-small cell lung cancer (NSCLC)
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-1
For a full list of participation criteria, please visit ClinicalTrials.gov.
Applicable Disease SitesLung Cancer, Non-Small Cell
Participating InstitutionsIndiana University (IU)
  • Eskenazi Hospital
  • Indiana University Hospital / IU Simon Cancer Center
Roudebush VA Medical Center
  • Roudebush VA Medical Center
Treatment TypeOther